Future trends in managing hepatitis C
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 33 (1), 51-61
- https://doi.org/10.1016/j.gtc.2003.12.001
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Future therapy of hepatitis CHepatology, 2002
- Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV doseJournal of Hepatology, 2002
- Developments in the treatment of chronic hepatitis CExpert Opinion on Investigational Drugs, 2002
- Recent advances in the molecular biology of hepatitis C virusJournal of Molecular Biology, 2001
- Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?Journal of Hepatology, 2001
- Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in MiceHepatology, 2000
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary resultsLiver International, 1998
- Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial†Hepatology, 1998
- Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.Gut, 1996